Comparison between Eris Lifesciences IPO and S.Chand & Co. IPO.
Eris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while S.Chand & Co. IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Eris Lifesciences IPO is up to ₹1,740.49 Cr whereas the issue size of the S.Chand & Co. IPO is up to ₹728.56 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of S.Chand & Co. IPO is ₹670.00 per share.
| Eris Lifesciences IPO | S.Chand & Co. IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹5 per share |
| Issue Price (Lower) | ₹600.00 per share | ₹660.00 per share |
| Issue Price (Upper) | ₹603.00 per share | ₹670.00 per share |
| Issue Price (Final) | ₹603.00 per share | ₹670.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 24 shares | 22 shares |
| Fresh Issue Size | 0 shares | 48,50,746 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹325.00 Cr |
| OFS Issue Size | 2,88,75,000 shares | 60,23,236 shares |
| OFS Issue Size (Amount) | up to ₹1,740.49 Cr | up to ₹403.56 Cr |
| Issue Size Total | 2,88,75,000 shares | 1,08,73,982 shares |
| Issue Size Total (Amount) | up to ₹1,740.49 Cr | up to ₹728.56 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while S.Chand & Co. IPO opens on Apr 26, 2017. The closing date of Eris Lifesciences IPO and S.Chand & Co. IPO is Jun 20, 2017, and Apr 28, 2017, respectively.
| Eris Lifesciences IPO | S.Chand & Co. IPO | |
|---|---|---|
| Anchor Bid Date | Jun 15, 2017 | Apr 25, 2017 |
| Issue Open | Jun 16, 2017 | Apr 26, 2017 |
| Issue Close | Jun 20, 2017 | Apr 28, 2017 |
| Basis Of Allotment (Tentative) | Jun 23, 2017 | May 04, 2017 |
| Initiation of Refunds (Tentative) | Jun 27, 2017 | May 05, 2017 |
| Credit of Share (Tentative) | Jun 28, 2017 | May 08, 2017 |
| Listing date (Tentative) | Jun 29, 2017 | May 09, 2017 |
| Anchor Lockin End date 1 | Jul 23, 2017 | Jun 03, 2017 |
| Anchor Lockin End date 2 | Sep 21, 2017 | Aug 02, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to S.Chand & Co. IPO P/E ratio of .
| Eris Lifesciences IPO | S.Chand & Co. IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹8291.25 Cr. | ₹2324.58 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Eris Lifesciences IPO Retail Individual Investors (RII) are offered 28,72,500 shares while in S.Chand & Co. IPO retail investors are offered 28,72,500 shares. Qualified Institutional Buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 21,74,796 shares in S.Chand & Co. IPO.
| Eris Lifesciences IPO | S.Chand & Co. IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,26,250 shares | 32,62,194 shares |
| Market Maker Reservation | ||
| QIB | 86,17,500 shares | 21,74,796 shares |
| NII | 43,08,750 shares | 16,31,098 shares |
| RII | 28,72,500 shares | 38,05,894 shares |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 2,88,75,000 shares | 1,08,73,982 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas S.Chand & Co. IPO subscribed 41.68x.
| Eris Lifesciences IPO | S.Chand & Co. IPO | |
|---|---|---|
| QIB (times) | 4.68x | 44.27x |
| NII (times) | 0.45x | 204.65x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.51x | 6.07x |
| Employee (times) | 0.86x | |
| Other (times) | ||
| Total (times) | 3.29x | 41.68x |
